DISE-HNS Effect Study
Assessment of the Effect of Hypoglossal Nerve Stimulation Therapy on the Site of Collapse During DISE
University Hospital, Antwerp
58 participants
Oct 21, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess the site, pattern and degree of upper airway collapse before and during hypoglossal nerve stimulation (HNS) treatment using clinical standard drug-induced sleep endoscopy (DISE) and using a novel, non-invasive method predicting site of collapse from raw polysomnography (PSG) data. Furthermore, outcomes will be compared between responders and non-responders.
Eligibility
Inclusion Criteria11
- years or older.
- Eligible for HNS-therapy:
- AHI between 15 and 65 events/hour
- BMI under 32 kg/m2
- Absence of complete concentric collapse of palate (CCC) on DISE
- Intolerance or failure of continuous positive airway pressure (CPAP)-treatment
- Intolerance or failure of mandibular advancement device (MAD)-treatment
- Combination of central and mixed apneas less than 25% of total apneas on recent PSG (not older than two years)
- Scheduled for HNS-implantation at the Antwerp University Hospital
- Capable of giving informed consent
- Baseline polysomnography planned or performed in the last 2 years at the Antwerp University Hospital
Exclusion Criteria2
- Patients will not receive HNS-therapy at the Antwerp University Hospital
- Known medical history of intellectual disability, memory disorders or current psychiatric disorders (psychotic illness, major depression, or acute anxiety attacks as mentioned by the patient).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The hypoglossal nerve stimulation (HNS) implantation and therapy will be performed according to the standard clinical practice without additional procedures. Information about the surgical procedure will be collected. HNS implant information and settings will be collected throughout the study until the last study measurement (one year follow-up PSG and DISE) for that patient. No additional measures or interventions as part of the research project will be performed during implantation or treatment with HNS.
A PSG at one-year follow-up is part of the standard follow-up pathway in patients receiving HNS therapy. In this study, PSG data will be collected from both baseline and one-year follow-up PSGs to assess treatment effect. Additionally, PSG data will be used for non-invasive prediction of the site and pattern of collapse using a novel, validated tool developed at our research group.
Drug-induced sleep endoscopy (DISE) is the clinical standard diagnostic test to assess site, pattern and degree of upper-airway collapse in OSA. Baseline DISE is part of the standard clinical pathway for HNS eligibility. In this study, DISE data will be collected from routine baseline DISE without any additional procedures for the patient. They will undergo an additional DISE at one-year follow-up to assess the effect of HNS-therapy on site, pattern and degree of collapse. Both DISEs will be performed according to routine clinical practice in the operating theatre. Sleep will be induced using 1.5 mg bolus injection midazolam and target-controlled propofol infusion (2.0 - 3.0 μg). A flexible fiberoptic nasopharyngoscope will be transnasally inserted. Site, pattern and degree of collapse will be assessed using a standardized scoring system. Other maneuvers, including chin-lift, the use of a simulation bite or lateral position of the head will be performed according to clinical practice.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06372847